Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. (EBS)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
6. 38
-0.8
-11.1421%
$
327.12M Market Cap
- P/E Ratio
7.42% Div Yield
2.24M Volume
-4.4 Eps
$ 7.18
Previous Close
Add Transaction
Day Range
6.15 6.73
Year Range
4.36 14.06
Want to track EBS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Emergent to donate 50,000 vaccine doses to address mpox outbreak in Africa

Emergent to donate 50,000 vaccine doses to address mpox outbreak in Africa

Emergent BioSolutions said on Monday it would donate 50,000 doses of its vaccine, ACAM2000, to the Democratic Republic of the Congo and other impacted countries of Burundi, Kenya, Rwanda and Uganda to address the current mpox outbreak.

Reuters | 2 years ago
Emergent BioSolutions: Speculative Buy Amid Potential Monkeypox Vaccine Approval

Emergent BioSolutions: Speculative Buy Amid Potential Monkeypox Vaccine Approval

Emergent BioSolutions is a key player in public health. Its flagship product, NARCAN, is central to combating the opioid crisis. EBS stock rally is likely driven by its smallpox vaccine, ACAM2000, which has potential implications for monkeypox. Potential refinancing and strategic turnaround efforts mitigate the company's financial challenges, including significant debt and cash burn.

Seekingalpha | 2 years ago
Why Emergent BioSolutions Stock Is Skyrocketing Today

Why Emergent BioSolutions Stock Is Skyrocketing Today

The European Centre for Disease Prevention and Control raised its risk level for mpox on Friday. The World Health Organization declared a global public health emergency on Wednesday.

Fool | 2 years ago
Vaccine Maker Emergent BioSolutions Expects Deeper Losses In 2024, Stock Sinks

Vaccine Maker Emergent BioSolutions Expects Deeper Losses In 2024, Stock Sinks

On Tuesday, Emergent BioSolutions Inc. EBS reported second-quarter 2024 sales of $254.7 million, down 25% year over year, beating the consensus of $190 million.

Benzinga | 2 years ago
Emergent BioSolutions Inc. (EBS) Q2 2024 Earnings Call Transcript

Emergent BioSolutions Inc. (EBS) Q2 2024 Earnings Call Transcript

Emergent BioSolutions Inc. (EBS) Q2 2024 Earnings Call Transcript

Seekingalpha | 2 years ago
Watch These 4 Overbought Stocks As Market Rotation Continues

Watch These 4 Overbought Stocks As Market Rotation Continues

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Marketbeat | 2 years ago
Emergent, J&J settle COVID vaccine supply deal dispute

Emergent, J&J settle COVID vaccine supply deal dispute

Emergent BioSolutions said on Monday Johnson & Johnson has agreed to pay $50 million to settle claims related to a terminated manufacturing deal for the latter's COVID-19 vaccine.

Reuters | 2 years ago
Why Is Vaccine Maker Emergent BioSolutions Stock Trading Higher On Tuesday?

Why Is Vaccine Maker Emergent BioSolutions Stock Trading Higher On Tuesday?

Nvidia Corp NVDA is trading lower Tuesday amid reports that the company faces antitrust charges from French regulators.

Benzinga | 2 years ago